ABSTRACT: Simultaneous stimulation of ex vivo pancreatic islets with dynamic oxygen and glucose is a critical technique for studying how hypoxia alters glucose-stimulated response, especially in transplant environments. Standard techniques using a hypoxic chamber cannot provide both oxygen and glucose modulations, while monitoring stimulus-secretion coupling factors in real-time. Using novel microfluidic device with integrated glucose and oxygen modulations, we quantified hypoxic impairment of islet response by calcium influx, mitochondrial potentials, and insulin secretion. Glucoseinduced calcium response magnitude and phase were suppressed by hypoxia, while mitochondrial hyperpolarization and insulin secretion decreased in coordination. More importantly, hypoxic response was improved by preconditioning islets to intermittent hypoxia (IH, 1 min/1 min 5−21% cycling for 1 h), translating to improved insulin secretion. Moreover, blocking mitochondrial K ATP channels removed preconditioning benefits of IH, similar to mechanisms in preconditioned cardiomyocytes. Additionally, the multimodal device can be applied to a variety of dynamic oxygen-metabolic studies in other ex vivo tissues. E x vivo study of islets of Langerhans, 50−400 μm spheroidal aggregates of pancreatic endocrine cells, under controlled microenvironments is critical for understanding islet physiology. When islets are exposed to stimulatory glucose in the blood, uptake and glycolysis leads to ATP production, which closes up ATP-sensitive K+ (K ATP ) channels and results in calcium influx that triggers the exocytosis of insulin granules.
Islets are capable of this glucose-insulin response because they are highly perfused in vivo, each within one cell length from a capillary vessel. Their insulin secretion is thus significantly influenced by the dynamics of blood flow and oxygen supply in addition to glucose gradients. Yet once the islets are isolated, both oxygen and nutrient supplies are constrained to a 100 μm perimeter because of diffusion limitations. 3 Recreating islet's physiological oxygen and glucose dynamics, key to in vitro and ex vivo studies, is difficult with hypoxic chambers that require elaborate flow and prevent continuous monitoring of islet functions. Additionally, transplant therapies for type I diabetes exposed isolated islets to hypoxia in the hepatic portal system, 4, 5 which has much lower PO 2 (<2%, 5−15 mmHg) compared to physiological pancreas (5.6%, 40 mmHg), for up to two weeks until revascularization. 6, 7 These hypoxic exposures are suggested to impair islet's glucose-insulin coupling mechanism. 8, 9 Among the coupling factors, calcium signaling, mitochondrial potential, and insulin kinetics can be easily monitored using microfluidics, 10−13 but quantification of their hypoxic impairment is stymied by the lack of simultaneous stimulation and monitoring techniques. Therefore, combining microfluidic control of oxygen and islet monitoring can improve islet hypoxia studies. Furthermore, tissues affected by ischemia and hypoxia could be trained or preconditioned for subsequent exposures. Preconditioning effects, first reported in Murry et al. 1986, 14 demonstrated that pre-exposure to ischemia provided protection against subsequent cardiac infarctions. Preconditioning against cardiac infarction was also later demonstrated with intermittent hypoxia (IH). 15 Similarly, ischemic preconditioning improves kidney graft function after transplantation 16 and also protects against strokes in neural tissues, 17 showing pervasive effects in numerous hypoxic tissues. In addition, evidence showed that K ATP openers can benefit islets, 18, 19 suggesting preconditioning mechanism similar to cardiomyocytes may exist for islets. However, ischemic 20 and IH 21, 22 preconditioning have not been achieved in islets, despite the serious hypoxic exposures during pancreas procurement 23 and islet transplantation. Those dynamic hypoxia studies were complicated by the slow, inefficient hypoxic chambers that prevented real-time islet functional assessments. Thus, the simultaneous modulation of glucose and hypoxia, especially transient dynamics at microscale-level, represents a key technique to enable novel IH functional studies and achieve islet preconditioning.
To enable functional studies of islet hypoxia and IH, we built a multilayered microfluidic device based on our previous islet perifusion (vs physiological perfusion) 24, 25 and cell-culture oxygen gradient devices. 26 It combines proven islet perfusate control with direct oxygen control in a stimulation sandwich, as shown in Figure 1a −d. Furthermore, as the gas is continuously delivered via computerized microinjectors, we can modulate the oxygen concentration from 21% to close to 0% digitally with transient time less than 60s. The dynamic controls of oxygen and glucose microenvironment at the microscope allow a realtime multimodal protocol that would not be possible or extraordinarily cumbersome using standard hypoxic chambers. Using this device, calcium signaling, mitochondrial potentials, and insulin kinetics were monitored, allowing us to investigate (1) quantitative hypoxia vs islet glucose response, (2) IH preconditioning for hypoxia, and (3) multiparametric dynamics of IH mechanism in islets.
■ EXPERIMENTAL SECTION
Microfluidics and Microinjector System. The device comprises three polydimethylsioloxane (PDMS) layers of microfluidics: glucose channel, oxygen channel, and microwell, Figure 1a . The glucose channel layer was fabricated using softlithography with a 700 μm SU8−2150 master, while the gas and microwell layers were made with 100 μm SU8−2100 masters. Then, degassed PDMS was spun onto the microwell master at 900 rpm twice to form a 200 μm gas-permeable membrane layer. Degassed PDMS was also molded over the glucose, gas, and blank masters at 80°C for 3 h to form the remaining layers. Access ports for all layers were punched and an 8 mm diameter, 250 μL chamber was also punched in the gasket layer. The layers were bonded with 30s of exposure from a plasma wand (ETP, Inc.) and then baked at 120°C for 3 h. Lastly, the completed device was leak-tested with simultaneous loading of water and compressed air at 2 psi.
To control the oxygen, a microinjector system was built with two precision microdispensing nozzles acquired from The Lee Company and connected with their outputs in a T-shaped mixer tubed to the microfluidic device, Figure 1c . Inputs of 0% and 21% oxygen with 5% CO 2 and balance nitrogen were connected to respective nozzles, with pressure adjusted to 2 psi equally. These microinjectors were controlled with a USB National Instrument TTL controller. A laptop ran the Labview script to control both nozzle openings, providing concentrations between 0 and 21% in 1% increments. The custom Labview program also provided up to five timing stages for modulating intermittent oxygen. In addition, the laptop was equipped with a USB FOXY Probe (Ocean Optics, Inc.) to measure gaseous and aqueous oxygen concentrations.
Islet Isolation and Preparation. C57BL/6 mice islet donors were euthanized with CO 2 and 3% isoflurane, followed by cervical dislocation. Dissection was done with V-incision at the genital area and moving the bowel to clearly expose the bile duct. The ampulla on the surface of duodenum was clamped with a hemostat. The pancreas was then distended (inflated) through the bile duct with a 30-gauge needle syringe containing 2 mL of cold collagenase solution (0.375 mg/mL in HBSS) starting at the gall bladder. The pancreas was then removed and placed in 2 mL of collagenase solution in 37°C water bath for 12 min. At 80%, the digestion was stopped and washed twice by adding cold HBSS and centrifuging at 284 g's (Beckman J6-MI) for 30 s at 4°C. The islets were purified using a discontinuous Ficoll density gradient of 1.108, 1.096, 1.069, and 1.037 kg/m 3 by centrifugation at 640 g and 4°C and picked up from the interface between 1.069 and 1.096 layers. The islets were washed two more times with cold HBSS via the centrifuge. Then, the islet pellet was resuspended in 10 mL RPMI-1640 containing 10% FBS, penicillin, streptomycin, and 20 mM HEPES and incubated in Petri-dishes (37°C, 5% CO 2 ). All islets were cultured postisolation for 1 day prior to use in experiments.
Buffer, Islet Loading, and Insulin ELISA. All perfusates were prepared in Krebs Ringer bicarbonate buffer: 129 mM NaCl, 5 mM NaHCO 3 , 4.7 mM KCl, 1.2 mM KH 2 PO 4 , 1 mM CaCl 2 ·2H 2 O, 1.2 mM MgSO 4 ·7H 2 O, 10 mM HEPES pH 7.35−7.40, 2 mM basal glucose, and 5% FBS. Stocks of Fura-2 a.m. in DMSO and Rh123 in 100% ethanol were added to Krebs buffer at final concentrations of 5 μM and 2.5 μM, respectively. The islets were incubated in 2 mL of Krebs buffer containing both Fura-2 and Rh123 for 30 min prior to loading via the aqueous microchannel. Approximately 10 islets were loaded for Fura-2 and Rh123 monitoring and 20 for insulin experiments. The islets were then perfused for 5 min to wash away excess dyes. Perfusate flow at 250 μL/min was provided by a Gilson Minipulse 2 peristaltic pump and heated on a 60°C hot plate upstream of the microfluidic device, which was mounted on an inverted Leica S6F with 37°C heated stage. There was no flow during the oxygen modulation to prevent convective disturbance of oxygen equilibrium at the islets. During glucose stimulation, effluent from the device was tubed to a Gilson 203 fraction collector and collected 4 min before stimulation and 3 min after wash at 1 sample/minute. Fractions were immediately frozen at −20°C and later thawed for 96-plate insulin ELISA measurements (Mouse Insulin, Mercodia, Sweden). The plates were read in a Biotek Synergy 2.
Data and Statistical Analysis. An inverted Leica S6F microscope provided simultaneous Fura-2 and Rh123 measurements. These dyes are sensitive to intracellular calcium and mitochondrial hyperpolarization, respectively. Fura-2 was excited at 340 and 380 nm and measured at 510 nm while Rh123 was excited at 495 nm and measured at 530 nm. When Fura-2 binds to available calcium, the dye's excitation maximum shifts from 380 to 340 nm, allowing a ratiometric measurement of 340 nm over 380 nm intensity to remove dye loading and photobleaching effects. Additionally, every experiment began with a standard pulse at 21% oxygen. Subsequent ratios were then normalized against the magnitude of this pulse and expressed as "Fura Ratio %". Rh123 fluorescence, which is quenched by mitochondrial hyperpolarization, was also analyzed with similar normalization. The insulin ELISA measurements were expressed as an index of the maximum value over the baseline average to account for the varying number of islets in the experiments. For transplants and islet physiology, it is common practice to express the stimulated insulin as an index over the basal levels.
In the hypoxia and IH calcium monitoring experiments, n = 3 experiments were conducted for each condition. For the multiparameter preconditioning experiments, n = 4 experiments were conducted for calcium measurements, while n = 3 experiments were conducted for mitochondria and insulin measurements at each condition; 10−20 islets were loaded in each experiment as described in the islet loading section. For the multiparameter preconditioning experiments, two-tailed ttests were performed to calculate p values for the differences between the means of 21% versus 5%, 5% versus preconditioning, and diazoxide versus 5-hydroxydecanoate (5HD) conditions.
■ RESULTS AND DISCUSSION
Multimodal Stimulation of Glucose, Oxygen, and Flow. The multilayered microfluidic device provides controlled perfusate and oxygen microenvironments with aqueous flow in the top layer and gas modulation in the bottom. For perfusate control, stimulatory flow at 250 μL/min can reach equilibrium within 3 min in the chamber, as shown by FITC dye mixing in Figure 2a . With the islets loaded, stimulatory glucose concentrations, that is, 7, 14, or 25 mM, can be introduced into the microwelled chamber. These concentrations correspond to physiological glucose levels for basal, postmeal, and diabetic conditions in mice, respectively. For oxygen control, microinjectors mixing of 0% and 21% O 2 inputs can deliver final oxygen concentrations of 0%, 5%, 10%, or 21% at the microwelled membrane where the islets are resting. Similar to recent techniques, 27−29 gas diffusion through this 200 μm PDMS membrane provides direct delivery of oxygen to the islets, in contrast with standard hypoxic chamber that requires circulating gas to cross millimeter thicknesses of bulk aqueous medium. Note that the diffusion time is inversely proportional to the square of the thickness, resulting in equilibration time in seconds for our device compared to hours with hypoxic chambers. 30 Additionally, the computerized gas control can modulate IH between 5% and 21%, achieving 2-min cycles as shown in Figure 2b . Other conditions can also be generated (see Supporting Information Figure 1) . Note that the oxygen sensor Cycling of oxygen between 5% and 21% is possible with 1 min period as measured both at the gas delivery (diffused) and surface of microwells (dissolved).
has a delay time of 15−20s in gas and 30−45s in aqueous media. Thus actual transient performance may be faster than measured. Gas fraction of 5% oxygen is a standard for hypoxia in cardiomyocytes and other tissue systems. 31, 32 The ability to vary with this range allows us to better quantify hypoxia and IH parameters at the ex vivo level with a precision previously not possible.
Islet Glucose−Calcium Response Is Depressed by Hypoxia. During islet's glucose−insulin response, a stimulatory pulse of glucose results in a pulse in intracellular calcium, which triggers insulin secretion. This calcium pulse has a biphasic profile with an initial dip (phase 0) corresponding to calcium sequestration in the endoplasmic reticulum, followed by an overshoot (phase 1) and oscillatory plateau (phase 2) that are both associated with transient membrane K ATP channels. 33, 34 To quantify this calcium response to hypoxia, Fura-2 labeled islets were loaded into the multimodal device and exposed to 21%, 10%, and 5% oxygen, while monitoring their calcium signaling. Under 21% oxygen flow, normoxic for ex vivo islets, the calcium influx showed a standard biphasic profile with magnitude 1.3 times above baseline in response to 14 mM glucose. Subsequent hypoxic pulses were normalized against this normoxic pulse. When the islets were exposed to 5% hypoxia for 30 min (zero flow to prevent convective oxygenation), their baseline calcium increases, as shown in Figure 3a . After this exposure, the calcium pulse lost both magnitude and phase information. Additional incubation of 10 min hypoxia, followed by a second pulse of glucose, did not alter the response. Quantitatively, the pulse height was depressed below 50% of the normoxic pulse, for both 10% and 5% hypoxia. Qualitatively, 5% hypoxia showed softened phase 0 dip, rounded phase 1 overshoot, and suppressed phase 2 oscillations compared to both 10% and normoxic profiles, as shown in Figure 3b .
We further investigated the time and glucose-dependence exposure of 5% hypoxia. At 14 mM glucose, 0 min exposure, i.e. no prior exposure, reduced phase 2 magnitude to 75% of the original pulse. After 10 min of exposure, this dropped to below 50%. Beyond 20 and 30 min, the hypoxic magnitude settled around 30% as shown in Figure 3c . On the other hand, with 20 min of exposure at 5%, all three physiological glucose concentrations, 7, 14, and 25 mM, resulted in depressed pulse magnitudes compared to 21%. In summary, prominent hypoxic response occurred at 5% oxygen concentration, and the effects could not be compensated with increased glucose concentrations.
In vitro, intracellular calcium increases resulted from exposure to hypoxia have been reported and attributed to cell membrane channel deficiencies or calcium release from endoplasmic reticulum and mitochondria storages. 35 Our data also showed a baseline calcium increase during exposures to 5% hypoxia, Figure 3a . Furthermore, hypoxia has been previously demonstrated to suppress insulin secretion, 8, 9 with 5% hypoxia inducing stronger suppression than 10%. 31, 32 The calcium monitoring results in this study corroborate this finding. One distinction that needs to be made is that physiological oxygenation reduces PO 2 to 40 mmHg (5.6%) in native pancreas, while isolated islets are exposed to 150 mmHg (21%) as their normoxic level. However, both reduction of oxygen to 5% ex vivo and corresponding transplant to hepatic portal vein at 5−15 mmHg or <2% have strong hypoxic effects. 21, 31 Furthermore, our dynamic device demonstrated more than just lower calcium response amplitudes, but also reduced phase 0−2 features as evident in Figure 3b . This reduction or dampening of the K ATP -dependent overshoot and oscillation in hypoxia could possibly be due to the decrease of ATP at the mitochondria. 36 In contrast, other studies have only reported end point changes without dynamics, compared to our in situ hypoxic measurements. IH Improves Islet Glucose−Calcium Response under Hypoxia. To improve islet's response under hypoxia, islets were pre-exposed to IH at 1 min 5% and 1 min 21% cycling totaling 60 min as a preconditioning to hypoxia, as shown in Figure 4a . Additional incubation of 10 min hypoxia did not reverse the response back into hypoxia, suggesting the protection cannot be removed by further exposure to continuous hypoxia. This IH protection improved islet response magnitude to 80% of the normoxic pulse, even operating under hypoxia, as shown in Figure 4b .
We further characterized the timing and cycling parameters of IH in order to optimize the preconditioning of islets. Shortening the hypoxic cycling to 1 min/1 min, as shown in Figure 4c , provided the best pulse magnitude. When the period was fixed at 1 min/1 min and the total number of IH cycles was increased from 4 to 30, there was an improvement in magnitude as well. However, when the cycling was increased to 60, the preconditioning benefit was removed. This cutoff in preconditioning duration (<2 h) could be a result of the limited volume (250 μL) of Krebs Ringer buffer in the chamber compared to a continuous flow of culture medium.
In comparison to other preconditioned tissues, IH applied to rat myocardium at five 12 min cycles (6%/21% oxygen) showed protection against ischemia-reperfusion injury up to 24 h after treatment. 5 Furthermore, myocardium IH protocols (1 min cycles) showed preference for longer treatment durations, with 4 h IH having smaller infarction size than 30 min IH protocols. 31 Consistent with myocardium, islet preconditioning demonstrated here is also optimal with shorter minute-scaled cycling for hour-long durations.
Insulin Secretion Is in Turn Improved by IH Preconditioning via Mitochondrial K ATP Channels. The effects of hypoxia and IH preconditioning on calcium dynamics were paralleled by changes in insulin secretion and mitochondrial potential, as measured by off-chip insulin ELISA and Rhodamine 123 (Rh123) fluorescence, respectively, Figure 5 . Insulin fractions were collected at 1 min intervals and expressed as an index of stimulation over baseline. The hypoxic pulse rendered insulin response down to basal levels (in some cases below baseline) while preconditioning improved insulin to 85% Insulin secretion, along with calcium and mitochondrial hyperpolarization, is also improved by preconditioning via mitochondrial K ATP channels. Combined Fura-2, insulin, and Rh123 responses for different oxygen and chemical conditions: 21% oxygen, 5% oxygen, preconditioning (P+5%), diazoxide (D+5%), and 5HD (5HD+P+5%). Diazoxide is consistent with preconditioning while 5HD negates the benefits of preconditioning by opening and blocking K ATP channels, respectively. Two-tailed t tests: 5% vs 21%, 5% vs P+5%, D+5% vs 5HD+P+5%; *p < 0.05, **p < 0.01, ***p < 0.001. of normoxia. Mitochondria hyperpolarization, monitored with Rh123 uptake and self-quenching, was improved with IH preconditioning compared to hypoxia exposure alone. Preconditioning also showed sensitization of hyperpolarization with faster response than normoxic pulses (see Supporting Informaton Figure 2) .
The observed benefit in hyperpolarization, suggestive of mitochondrial K ATP channel involvement in preconditioning, was investigated using channel opener diazoxide and blocker 5-hydroxydecanoate (5HD). These channel modifiers are extensively used to demonstrate cardiomyocyte preconditioning. 37, 38 Islets were incubated in 100 μM diazoxide for 10 min and washed in Krebs Ringer buffer for 10 min prior to hypoxia and glucose stimulation. Diazoxide incubation provided preconditioning benefits to islets under 5% hypoxia (see Supporting Information Figure 3 for Fura-2 profile). Conversely, islets treated with IH (1 min/1 min cycle, 60 min total) and 100 μM 5HD simultaneously failed to be preconditioned and showed typical hypoxic response (see supplementary Figure 4 for Fura-2 profile). Both mitochondrial hyperpolarization and insulin secretion were improved with diazoxide compared to IH+5HD, as shown in Figure 5 . Though not statistically significant, diazoxide had higher average calcium and insulin responses while its mitochondrial hyperpolarization was less than that of IH preconditioning alone. This suggests IH preconditioning is better at enhancing mitochondrial response rather than solely altering calcium-dependent insulin secretion.
By applying rapid, minute-scaled IH, we were able to demonstrate the first ex vivo preconditioning for pancreatic islets with improvements in insulin secretion and dynamics. By optimizing cycling to 2 min periods totaling 60 min durations, hypoxic islets were preconditioned to achieve calcium, mitochondria, and insulin responses that are over 80% of the normoxic response. Although islet preconditioning is not wellunderstood, our islet preconditioning results are consistent with the mechanistic view of mitochondrial K ATP channel preconditioning. 37−39 Specifically, our results showed IHpreconditioned mitochondria hyperpolarizes more than hypoxic conditions, but also does so faster than normoxia (see Supporting Information Figure 2) . Furthermore, mitochondrial specific blocker 5HD 40 unlike diazoxide, does not affect glucose-related K ATP responses and insulin secretions. Taken together, our first demonstration of IH preconditioning in pancreatic islets suggests that mitochondria and its associated K ATP channels play a critical role in the preconditioning process while glucose-related K ATP channels are unmodified. We achieved this because our device can modulate mitochondrial preconditioning both pharmacologically and metabolically (i.e., diazoxide/5HD and IH), while simultaneously probing glucose−insulin functions.
■ CONCLUSION
We have demonstrated a novel microfluidic device capable of simultaneous modulation of oxygen and perfusate deliveries at islet's microscale-level. It enabled detailed quantification of the hypoxia impairments of glucose−insulin coupling factors. More importantly, the use of the device provided the first report of IH preconditioned islets with improved insulin secretion under hypoxia, a feat previously unachievable using either hypoxic chambers or competing microfluidic devices. Additionally, we demonstrated that IH preconditioning of islets is consistent with reported mitochondrial K ATP preconditioning mechanism.
In the future, additional gas-controlled perfusate channels could be added to enable stable oxygen concentrations while maintaining rapid membrane-diffused oxygen to the islets without disruption.
A direct application of islet IH preconditioning is improving islet function prior to transplants. The ability to improve islet function not only addresses hypoxia injury while awaiting revascularization but can also optimize the number of isolated islets required for each transplant. Beyond islet preconditioning, the multimodal device described here can be applied to studying general IH and hypoxia conditioning for other microtissues or tissue preparations, such as brain slices or embryoid bodies. For example, detailed studies of K ATP channel function could explain why preconditioning works so well in cardiomyocytes, and be used to benefit other tissues. Additionally, mechanisms in lipotoxicity and glucosetoxicity are suspected to be dependent on reactive oxygen species and high oxygen metabolism. 41 Both aspects can be investigated by modulating gas phase oxygen in addition to aqueous oxygen scavengers using this multimodal device. Lastly, many developmental and regenerative mechanisms in stem-cell differentiation and cell−cell interactions depend on oxygen gradients. The groundwork laid out by this multimodal oxygen device can be adapted to many of these challenging unanswered questions.
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